SXTC
China SXT Pharmaceuticals, Inc.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest +0.1% to 65.6K shares. 1.0 days to cover, ≈5.0% of shares.
- SocialQUIET
Crowd 44° (neutral) this week from 5 mentions: 0 bullish, 1 bearish. No setup call.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Sep 30, 2026| Oct 23, 2026 | Resumption Scheduled | Resumed |
| Aug 7, 2026 | Resumption Scheduled | Resumed |
SecBot reports
12 filings · 1 press release · 1 bullish · 10 bearish · 1 neutral- BULLISH 6-KOct 21, 2026
China SXT Pharmaceuticals terminated the over-allotment option from its October 8, 2026 registered…
The termination caps the total dilution from this offering at the base 8 million units. Monitor for any subsequent capital raises or financial distress signals given the company's small market cap…
- NEUTRAL SC 13GOct 15, 2026
Orca Capital AG disclosed a passive 9.9% stake in China SXT Pharmaceuticals via a Schedule 13G…
Monitor for any conversion of the 13G to a 13D, which would signal activist intent. The 9.9% stake is near the blocker limit, so further open-market accumulation is unlikely without a formal waiver.
- BEARISH 6-KOct 9, 2026
China SXT Pharmaceuticals (SXTC) filed a 6-K disclosing a securities purchase agreement for a…
The zero-price warrant exercise feature creates a massive overhang of up to 72 million potential shares, which will likely pressure the stock price. Monitor for immediate warrant exercises and…
- BEARISH 424B5Oct 9, 2026
China SXT Pharmaceuticals is conducting a dilutive offering of up to 8,000,000 units (plus an…
The extreme dilution from the zero-price exercise warrants will likely overwhelm any near-term cash infusion. Monitor for immediate selling pressure as the market prices in the potential 30x-60x…
All SXTC filing & press-release reports (13)
- 6-K reportOct 21, 2026
- SC 13G reportOct 15, 2026
- 6-K reportOct 9, 2026
- 424B5 reportOct 9, 2026
- 6-K reportOct 8, 2026
- 6-K reportOct 8, 2026
- EFFECT reportSep 17, 2026
- 6-K reportAug 28, 2026
- 424B5 reportJul 24, 2026
- 424B5 reportJun 1, 2026
- 6-K reportMay 4, 2026
- 424B5, 6-K reportApr 9, 2026
- PRESS-RELEASE reportMar 23, 2026